Orixone S 500mg/250mg Injection
Marketer
Otik Biotec
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Orixone S 500mg/250mg Injection
Combiflox, a 500mg/250mg injectable formulation, combats bacterial infections by inhibiting microbial proliferation. Administer this medication solely under a physician's guidance; adhere strictly to the prescribed dosage schedule. Complete the entire course of treatment, regardless of symptom improvement, as premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; escalate any adverse effects to your doctor promptly. Seek immediate medical attention for allergic reactions (e.g., rash, itching, edema, dyspnea). Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Prioritize rest, nutrition, and hydration for optimal recovery. Your doctor may order tests to monitor the drug's effects.
Primary Ingredients of Orixone S 500mg/250mg Injection
No text provided to rephrase.
Uses of Orixone S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Orixone S 500mg/250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Orixone S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Orixone S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Orixone S 500mg/250mg Injection works:
The injectable formulation Orixone S (500mg Ceftriaxone/250mg Sulbactam) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial mechanism disrupts bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam, by counteracting bacterial resistance enzymes, augments Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Orixone S 500mg/250mg Injection does not interact negatively with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Orixone S, 500mg/250mg, is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Orixone S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Orixone S 500mg/250mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Orixone S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation Orixone S 500mg/250mg requires careful administration in individuals with advanced hepatic impairment. Dosage modification of Orixone S 500mg/250mg Injection may be necessary. Medical advice is recommended. Altering the dose of Orixone S 500mg/250mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Orixone S 500mg/250mg Injection :
Should you forget to administer a dose of Orixone S 500mg/250mg Injection, seek advice from your physician.
Facts to Know About Orixone S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently